Table 2.
Classification of the Identified Types of NOD-Like Receptors (NLRs) and Their Main Activators
| NLR | Main Activators |
|---|---|
| NLR A | |
| CIITA | IFN-γ |
| NLR B | |
| NAIP1/2 | Injectisome |
| NAIP5/6 | Flagellin |
| NLR C | |
| NOD1 (NLRC1) | Peptidoglycan iE-DAP |
| NOD2 (NLRC2) | Peptidoglycan Muramyl dipeptide ssRNA |
| NLRC3 | Undetermined |
| IPAF (NLRC4) | Injectisome/flagellin (mediated by NAIPs) |
| NLRC5 | IFNγ LPS Poly I:C |
| NLRX1 | LPS Viral RNA |
| NLRP | |
| NLRP1 | Anthrax lethal toxin Toxoplasma gondii ATP depletion Muramyl dipeptide |
| NLRP2 | LPS/TNF-α |
| NLRP3 | K+ efflux Bacterial toxins and RNA Nigericin Aluminum hydroxide ATP Cholesterol and uric acid crystals Particulate matter Mitochondrial damage |
| NLRP4 | Viral DNA/RNA |
| NLRP5/8/13/14 | Undetermined |
| NLRP6 | Viral RNA TLR ligands Lipotheicoic acid |
| NLRP7 | Bacterial acylated lipoproteins Lysosomal proteases? K+ flux? |
| NLRP9 | dsRNA |
| NLRP10 | NOD1 activation |
| NLRP11 | TLR4 ligands |
| NLRP12 | ATP TLR2 ligands Yersinia pestis |
ATP = adenosine triphosphate; CIITA = major histocompatibility complex class II transactivator; iE-DAP = γ-D-glutamyl-meso-diaminopimelic acid; IFN = interferon; K = potassium; IPAF = interleukin-1b (IL-1b)-converting enzyme-protease-activating factor; LPS = lipopolysaccharide; NLR = nucleotide-binding oligomerization domain-like receptors; NAIP = Baculoviral IAP repeat-containing protein 1; NLRP = nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain-containing receptor; NOD1 = Nucleotide-binding oligomerization domain-containing protein 1; TNF = tumor necrosis factor; other abbreviations as in Table 1.